Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01780038 · ClinicalTrials.gov registry record · NA
Smokers' Response to Nicotine Dependence Genotyping
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01780038 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 24 participants.
The verdict
NCT01780038, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Innovative strategies to reduce adult smoking prevalence include using genetic information to motivate cessation and, ultimately, to tailor cessation pharmacotherapy. Success of these interventions depends, in part, on smokers' interest and participation in genetic testing related to cessation and their understanding and use of the results (i.e., their genetic literacy). The recent availability of genetic risk testing for a nicotinic acetylcholine receptor gene (CHRNA3) variant (rs105173) associated with nicotine dependence makes it highly feasible to investigate smokers' interest in and use of genetic information about nicotine dependence. Therefore, the primary purpose of this study is to determine the impact of an intervention that provides smokers with an educational session about genetic contributions to smoking and nicotine dependence plus their genotype results for rs1051730 on smoking cessation outcomes compared to those who receive only the educational session. Secondary purposes are to determine: (a) the impact of genetic education and knowing personal genotype results on genetic literacy outcomes and (b) the feasibility of recruitment and retention methods in a study addressing genotyping for nicotine dependence. Primary outcomes are cessation-related behaviors and cognitions indicating abstinence. Secondary outcomes are cognitions and emotions indicating genetic literacy. Knowledge gained from this study has the potential for clinical translation so that as genotyping becomes part of smoking cessation, health-care providers can understand and address factors influencing smokers' adaptation to genetically-informed cessation treatment. The study will use a longitudinal, repeated measures design (experimental, control; N=90; 45/group). All participants will receive a 90-minute educational session about genetic contributions for smoking and nicotine dependence and will donate a buccal swab sample for genotyping. The investigators will then randomize particip
Interventions
- BEHAVIORAL Receipt of Genetic Results
- BEHAVIORAL No results given
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-11-14 |
| Est. Completion | 2013-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01780038
The ClinicalTrials.gov registry entry for NCT01780038 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Receipt of Genetic Results is the first listed.
NCT01780038 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01780038 about?
NCT01780038 is a clinical study titled "Smokers' Response to Nicotine Dependence Genotyping". Innovative strategies to reduce adult smoking prevalence include using genetic information to motivate cessation and, ultimately, to tailor cessation pharmacotherapy. Success of these interventions depends, in part, on smokers' interest and participation in genetic testing related to cessation and t...
What is the current status of trial NCT01780038?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-11-14. Estimated completion is 2013-08-31.
What interventions are being tested in trial NCT01780038?
The interventions under investigation include: Receipt of Genetic Results (BEHAVIORAL), No results given (BEHAVIORAL).
Who is sponsoring clinical trial NCT01780038?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.